Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hetero Drugs Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3477
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom research and manufacturing services to global biotechnology and pharmaceutical companies. Hetero offers products in various therapeutic areas which include HIV/AIDS, oncology, cardiovascular, neurology and hepatitis, among others. The company conducts research and development to develop new products. It markets its products through a network of marketing offices across the world. Hetero is headquartered in Hyderabad, Telangana, India.

Hetero Drugs Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hetero Drugs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Oasmia Pharma Enters into Marketing and Distribution Agreement with Hetero Drugs 11
Kadmon Amends Supply And Distribution Agreement with Camber Pharma 12
Stada Arzneimittel to Form Joint Venture with Hetero Drugs 13
Cipla Enters into Co-Marketing Agreement with Hetero Drugs 14
Furen Pharma to Form JV with Hetero Drugs for Oncology and AIDS 15
DFH Pharma Enters Into R&D Agreement With Hetero For HIV Drugs 16
Hetero Drugs Forms Joint Venture With Neopharma 17
Licensing Agreements 18
Hetero Enters into Licensing Agreement with VIVUS for STENDRA 18
Aurobindo Pharma, Cipla, Desano Pharma, Emcure Pharma, Hetero Labs and Laurus Labs Enter into Licensing Agreement with Medicines Patent Pool 19
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 20
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 21
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 22
Dr Reddy’s Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir 24
Gilead Sciences Enters into Licensing Agreement with Hetero Labs 25
Hetero Drugs Ltd – Key Competitors 26
Hetero Drugs Ltd – Key Employees 27
Hetero Drugs Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hetero Drugs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hetero Drugs Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oasmia Pharma Enters into Marketing and Distribution Agreement with Hetero Drugs 11
Kadmon Amends Supply And Distribution Agreement with Camber Pharma 12
Stada Arzneimittel to Form Joint Venture with Hetero Drugs 13
Cipla Enters into Co-Marketing Agreement with Hetero Drugs 14
Furen Pharma to Form JV with Hetero Drugs for Oncology and AIDS 15
DFH Pharma Enters Into R&D Agreement With Hetero For HIV Drugs 16
Hetero Drugs Forms Joint Venture With Neopharma 17
Hetero Enters into Licensing Agreement with VIVUS for STENDRA 18
Aurobindo Pharma, Cipla, Desano Pharma, Emcure Pharma, Hetero Labs and Laurus Labs Enter into Licensing Agreement with Medicines Patent Pool 19
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 20
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 21
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 22
Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir 24
Gilead Sciences Enters into Licensing Agreement with Hetero Labs 25
Hetero Drugs Ltd, Key Competitors 26
Hetero Drugs Ltd, Key Employees 27
Hetero Drugs Ltd, Other Locations 28
Hetero Drugs Ltd, Subsidiaries 28
Hetero Drugs Ltd, Joint Venture 29

List of Figures
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ITOCHU Corporation:企業のM&A・事業提携・投資動向
    ITOCHU Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ITOCHU Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Axalta Coating Systems Ltd:企業の戦略・SWOT・財務情報
    Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Oncgnostics GmbH-医療機器分野:企業M&A・提携分析
    Summary Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the met …
  • LifeNet Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeNet Health Inc (LifeNet Health) is a non-profit organization that specializes in regenerative medicine. It offers allograft bio-implants and organs for transplantation. The organization specializes in offering organ procurement, tissue banking and transplant services. It provides allogra …
  • University of Toronto-製薬・医療分野:企業M&A・提携分析
    Summary University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university offers courses in various fields such as applied science and engineering, architecture, landscape, design, arts and science, continu …
  • Mizuno Corp (8022):企業の財務・戦略的SWOT分析
    Mizuno Corp (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PT PLN (Persero):企業の戦略的SWOT分析
    PT PLN (Persero) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Sabre Corporation:企業の戦略・SWOT・財務分析
    Sabre Corporation - Strategy, SWOT and Corporate Finance Report Summary Sabre Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Oriental Cuisines Private Limited:企業の戦略・SWOT・財務分析
    Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report Summary Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Saizeriya Co., Ltd.:企業の戦略・SWOT・財務分析
    Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Shipbuilding Industry Corp:企業の戦略・SWOT・財務情報
    China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Petratherm Ltd (PTR):電力:M&Aディール及び事業提携情報
    Summary Petratherm Ltd (Petratherm) is a renewable energy company that carries out the business of exploration and development of emission-free geothermal energy projects. The company holds interest in Paralana Geothermal Energy Project located 600 km north of the city of Adelaide in South Australia …
  • SKYCITY Entertainment Group Ltd:戦略・SWOT・企業財務分析
    SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Calima Energy Ltd (CE1):石油・ガス:M&Aディール及び事業提携情報
    Summary Calima Energy Ltd (Calima Energy), formerly Azonto Petroleum Ltd is an oil and gas exploration and development company that invests in, acquires, explores, and produces oil and gas resources. The company provides acquisition, production, evaluation, exploration, development of oil and gas pr …
  • Innova Biosciences Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Innova Biosciences Ltd (Innova), a subsidiary of Sygnis AG is a provider of bioconjugation technologies and services. The company products include antibody labeling kits, antibody purification kits, affinity resins, gold nanoparticle kits, immunogen kits, rapid Ab labeling kits and others. I …
  • Northwest Biotherapeutics Inc (NWBO):医療機器:M&Aディール及び事業提携情報
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is …
  • Nobilis Health Corp (NHC):企業の財務・戦略的SWOT分析
    Summary Nobilis Health Corp (Nobilis Health), formerly Northstar Healthcare Inc is a healthcare development and management company that offers outpatient surgery and healthcare solutions. The center’s services include surgical services, surgery and critical patient education services. Its surgical s …
  • Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報
    Summary Prestige Brands Holdings Inc (Prestige) focuses on the marketing, sales and distribution of over-the-counter (OTC) healthcare and household cleaning brands. The company offers its products for digestive care; lice treatment, household cleaning; hygiene; oral care; pain relief; pediatric care …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆